2012 Fiscal Year Final Research Report
Development of strategy for treatment of secondary hyperparathyroidism based on clinical and cost-effectiveness
| Project/Area Number |
23790958
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Kidney internal medicine
|
|---|
| Research Institution | Tokai University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2011 – 2012
|
| Keywords | 人工透析学 |
|---|
| Research Abstract |
The objective of this study is to determine a reasonable strategy for treatment of secondary hyperparathyroidism based on clinical and cost-effectiveness.In the cost-effectiveness analysis of cinacalcet hydrochloride for severe secondary hyperparathyroidism, we showed that the use of cinacalcet is likely to be cost-effective for only those who cannot undergo parathyroidectomy (Komaba H et al. Am J Kidney Dis 60: 262-271, 2012).In the cost-effectiveness analysis of 99m_Tc-MIBI scintigraphy, we showed that this method is likely to be cost-effective for preoperative identification of ectopic parathyroid glands in hemodialysis patients with persistent or recurrent secondary hyperparathyroidism (Komaba H et al. 49th ERA-EDTA Congress, Paris).Finally, using retrospective cohort data of 2,292 maintenance hemodialysis patients, we demonstrated that treatment with lanthanum carbonate, a novel phosphate bidder, is independently associated with survival benefit among those with uncontrolled hyperphosphatemia (Komaba H et al.50th ERA-EDTA Congress, Istanbul).
|
